Rasmussen’s encephalopathy (RE): management

Evidence-based neurology checklist on rasmussen’s encephalopathy (re): management: Magnetic resonance imaging (MRI): features Hyperintensities: these are in the grey-white matter and the head of caudate Unilateral hemispheric cortical atrophy Contralateral atrophy: this develops slowly…

Magnetic resonance imaging (MRI): features

  • Hyperintensities: these are in the grey-white matter and the head of caudate
  • Unilateral hemispheric cortical atrophy
  • Contralateral atrophy: this develops slowly

Electroencephalogram (EEG): features

Potential immune treatments

Epilepsy treatments

Other treatments

References

  1. Bien CG, Granata T, Antozzi C, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis. Brain 2005; 128:454-471.
  2. Varadkar S, Bien CG, Kruse CA, et al. Rasmussen's encephalitis: clinical features, pathophysiology, and treatment advances. Lancet Neurol 2014; 13:195-205.
  3. Bittner S, Simon OJ, Gobel K, Bien CG, Meuth SG, Wiendl H. Rasmussen encephalitis treated with Natalizumab. Neurology 2013; 81:395-397.
  4. Pellegrin S, Baldeweg T, Pujar S, et al. Immunomodulation with azathioprine therapy in rasmussen syndrome: a multimodal evaluation. Neurology 2021; 96:e267-e279.
  5. Lagarde S, Villeneuve N, Trébuchon A, et al. Anti-tumor necrosis factor alpha therapy (adalimumab) in Rasmussen’s encephalitis: an open pilot study. Epilepsia 2016; 57:956-966.
  6. And 3 more. Subscribe to see the full list

Related checklists

Loading...